Evidence mapPaperPMID 36201598Full record

ReviewEndocrinology2022

Metformin's Impact on the Microvascular Response to Insulin.

Kaitlin M Love, Eugene J Barrett, William B Horton

Open access · bronzeAbstract readReview
In one paragraph

Review in Endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Potential Therapeutic Properties ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  2. Clinical Potential of Hydrogen Sulfide in Peripheral Arterial Disease.International journal of molecular sciences · 2023
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kaitlin M LoveDivision of Endocrinology and Metabolism, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA 22903, USA.ORCID 0000-0002-9352-393X
Eugene J BarrettDivision of Endocrinology and Metabolism, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA 22903, USA.ORCID 0000-0003-0689-4044
William B HortonDivision of Endocrinology and Metabolism, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA 22903, USA.ORCID 0000-0001-8081-1214
University of Virginia · US

Funding

Institutional Career Development CoreKL2TR003016 · NCATS · UNIVERSITY OF VIRGINIA · PI Jason Papin, BRADFORD B WORRALL · 2022 to 2023
$2.1M
Acute effects of hyperglycemia on heart and skeletal muscle microvasculatureR01HL142250 · NHLBI · UNIVERSITY OF VIRGINIA · PI EUGENE Joseph BARRETT · 2022 to 2022
$737k
Interdisciplinary Training in Systems & Biomolecular Data ScienceT32GM145443 · UNIVERSITY OF VIRGINIA · 2025 to 2025
$321k
NCATS NIH HHS KL2 TR003016NHLBI NIH HHS R01 HL142250NIDDK NIH HHS L30 DK126152NIGMS NIH HHS T32 GM145443
6 · The paper itself

Abstract

Metformin improves insulin's action on whole-body glucose metabolism in various insulin-resistant populations. The detailed cellular mechanism(s) for its metabolic actions are multiple and still incompletely understood. Beyond metabolic actions, metformin also impacts microvascular function. However, the effects of metformin on microvascular function and microvascular insulin action specifically are poorly defined. In this mini-review, we summarize what is currently known about metformin's beneficial impact on both microvascular function and the microvascular response to insulin while highlighting methodologic issues in the literature that limit straightforward mechanistic understanding of these effects. We examine potential mechanisms for these effects based on pharmacologically dosed studies and propose that metformin may improve human microvascular insulin resistance by attenuating oxidative stress, inflammation, and endothelial dysfunction. Finally, we explore several important evidence gaps and discuss avenues for future investigation that may clarify whether metformin's ability to improve microvascular insulin sensitivity is linked to its positive impact on vascular outcomes.

Indexed as

Insulin ResistanceMetforminGlucoseHumansHypoglycemic AgentsInsulinOxidative StressGlucoseHypoglycemic AgentsInsulinMetforminblood vesselsinsulin resistancemetforminmicrovessels

Identifiers

PMID36201598
PMCPMC10233257
OpenAlexW4302763610

What Socratic holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.